Top Clinical Trials companies in Norway by Net Cash Used Provided By Financing Activities

This ranking features the top 3 Clinical Trials companies in Norway ranked by Net Cash Used Provided By Financing Activities, totaling a Net Cash Used Provided By Financing Activities of USD 25.35 M, for February 07, 2025.

Norway

Clinical Trials
Net Cash Used Provided By Financing Activities
#
Name
Net Cash Used Provided By Financing Activities
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
BGBIO.OL

BerGenBio ASA

1

BGBIO.OL
USD 22.08 M
Dec. 31, 2023 USD 0.73 3.02%

Norway
2
LIFE.OL

Lifecare AS

2

LIFE.OL
USD 3.72 M
Dec. 31, 2023 USD 1.13 -2.55%

Norway
3
GENT.OL

Gentian Diagnostics ASA

3

GENT.OL
USD -451.41 K
Dec. 31, 2023 USD 4.31 4.92%

Norway
Frequently Asked Questions
  • Which Clinical Trials company in Norway has the highest Net Cash Used Provided By Financing Activities ?

    The Clinical Trials company in Norway with the highest Net Cash Used Provided By Financing Activities is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at USD 22.08 M.

  • Which Clinical Trials company in Norway has the lowest Net Cash Used Provided By Financing Activities ?

    The Clinical Trials company in Norway with the lowest Net Cash Used Provided By Financing Activities is Gentian Diagnostics ASA (Oslo Stock Exchange: GENT.OL) at USD -451.41 K.

  • What are the top 10 Clinical Trials companies in Norway by Net Cash Used Provided By Financing Activities ?

    The top 10 Clinical Trials companies in Norway by Net Cash Used Provided By Financing Activities are BerGenBio ASA, Lifecare AS and Gentian Diagnostics ASA.

  • What are the bottom 10 Clinical Trials companies in Norway by Net Cash Used Provided By Financing Activities ?

    The bottom 10 Clinical Trials companies in Norway by Net Cash Used Provided By Financing Activities are Gentian Diagnostics ASA, Lifecare AS and BerGenBio ASA.

SV Wall Street